Latest Stock Market News

This comes as Boat’s revenue fell 5% in FY24 to Rs 3,285 crore, while it halved losses to Rs 70.8 crore. Sources said there’s a consolidation underway in the sector and that the recent Diwali season lifted sales after several muted quarters. Boat recorded positive earnings before interest, taxes, depreciation, and amortisation (ebitda) in FY24.

Indian companies, excluding oil and gas, reported solid double-digit profit growth for the seventh consecutive quarter, although the pace of expansion slowed. While banks and finance companies performed well, overall earnings were subdued due to a higher base effect and rising interest costs.

Indian equity indices witnessed their sixth consecutive day of decline, marking the longest losing streak since October 7, as investor sentiment remained subdued. Despite signs of markets being oversold, the NSE Nifty fell by 0.11% while the BSE Sensex declined by 0.14%. Market analysts suggest a further slide is possible if Bank Nifty drops below its current level.

India witnessed its lowest monthly increase in demat accounts this financial year, adding 3.5 million in October, as market volatility, fueled by overseas fund withdrawals and a dip in benchmark indices, seemingly impacted investor sentiment.

If included, Zomato and Jio Financial Services could see inflows worth $607 million and $372 million, respectively, said JM. BPCL and Eicher Motors could see outflows of $223-$239 million.

A new study by the Securities and Exchange Board of India (SEBI) has revealed that listed companies in India frequently pay substantial royalties to related parties, often exceeding 20% of their net profits. The regulator is considering stricter regulations, including cumulative royalty limits and sunset provisions, to address concerns about potential financial risks and shareholder value erosion.

Global Health (Medanta) witnessed a 4.5% rise in net profit, reaching Rs. 130.8 crore in Q2FY25, driven by revenue growth from existing and new hospitals, coupled with increased patient numbers. Their revenue climbed 12.7% YoY, hitting Rs 975 crore, with EBITDA at Rs 247 crore, marking a 5.5% YoY increase.

Sobha Ltd reported a 3.3x QoQ and 74% YoY increase in Q2FY25 PAT to Rs 26.1 crore. Revenue grew 44% QoQ and 25% YoY to Rs 965 crore. Real estate collections reached Rs 1,222 crore, and sales value was Rs 1,178 crore with an average price realization of Rs 12,674 per sq ft. Kerala was a key performer with its best-ever quarterly sales.

Glenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net loss of Rs 180 crore in the corresponding quarter of the previous year.